-+ 0.00%
-+ 0.00%
-+ 0.00%

Cantor Fitzgerald Maintains Neutral on Rigel Pharmaceuticals, Raises Price Target to $23

Benzinga·05/07/2025 14:01:00
Listen to the news
Cantor Fitzgerald analyst Kristen Kluska maintains Rigel Pharmaceuticals (NASDAQ:RIGL) with a Neutral and raises the price target from $20 to $23.